Stock info Y-mAbs Therapeutics, Inc | Filter  Basic-Info

Stock: Y-mAbs Therapeutics, Inc (US broad)

Last Price 6.00 Max Price 17.99
Min Price 5.97 1 Year return 22.34
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review Y-mAbs Therapeutics, Inc

Loading...
Year Turnover Total sector Market share
2019 0 141,925 0.00 %
2020 21 170,231 0.01 %
2021 35 252,886 0.01 %
2022 65 238,496 0.03 %
2023 0 0 0.00 %

Advice Y-mAbs Therapeutics, Inc

No Records Found



News Y-mAbs Therapeutics, Inc

No Records Found

Annual reports Y-mAbs Therapeutics, Inc

No Records Found

Profile Y-mAbs Therapeutics, Inc

No Records Found

Results Y-mAbs Therapeutics, Inc

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
21
Costs
0
17
19
43
81
140
Profit
0
-17
-19
-43
-81
-119
Margin of profit
0.0
0.0
0.0
0.0
0.0
-575.13
ROI
0.0
-141.46
-23.32
-30.79
-40.74
-112.76

Balance Y-mAbs Therapeutics, Inc

Balance
2015
2016
2017
2018
2019
2020
Equity
0
12
82
141
199
106
Debt
0
5
10
11
17
26
Total assets
0
17
92
152
216
132
Solvency
0.0
69.87
89.17
92.50
91.93
80.15
Cash
0
17
90
148
207
115
Cashflow
0
-11
-16
-41
-74
-91
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.0
-2.15
-1.59
-3.62
-4.21
-3.48

Details Y-mAbs Therapeutics, Inc

Details
2016
2017
2018
2019
2020
Price
0.0
0.0
0.0
20.34
31.25
Eps
-0.52
-0.59
-1.50
-2.30
-2.97
Price/earnings-ratio
0.0
0.0
0.0
-8.84
-2.01
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
0.37
2.52
4.11
5.01
2.60
Market to book
0.0
0.0
0.0
0.25
0.44
Cashflow per stock
-0.34
-0.49
-1.21
-1.85
-2.24
Stocks
33
33
34
40
41
Market Cap
0.00
0.00
0.00
808.08
242.91

Dividend Y-mAbs Therapeutics, Inc

Price info Y-mAbs Therapeutics, Inc

Date
Price
05 Feb 2025
6.00
02 Feb 2025
5.97
21 Jan 2025
6.16
17 Jan 2025
6.18
09 Jan 2025
7.39
17 Dec 2024
9.92
10 Dec 2024
10.26
06 Dec 2024
10.30
03 Dec 2024
11.79
29 Nov 2024
11.88
13 Nov 2024
13.18
08 Nov 2024
15.55
05 Nov 2024
14.87
31 Oct 2024
14.85
29 Oct 2024
14.81
23 Oct 2024
14.85
19 Oct 2024
14.45
16 Oct 2024
14.30
14 Oct 2024
14.50
05 Oct 2024
14.16
02 Oct 2024
13.21
27 Sep 2024
12.82
20 Sep 2024
14.00
17 Sep 2024
13.01
13 Sep 2024
13.24
28 Aug 2024
15.17
26 Aug 2024
13.74
23 Aug 2024
13.32
11 Aug 2024
11.21
07 Aug 2024
11.12
Overig aandelennieuws
Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
Y-mAbs Therapeutics Announces U.S. FDA Clearance of Investigational New Drug Application for CD38-SADA
Y-mAbs Announces Publication in Cancers
Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology
Y-mAbs to Participate at Upcoming Investor Conferences in September
Logoanalist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo